Sartorius (OTCMKTS:SARTF – Get Free Report) will likely be announcing its results before the market opens on Thursday, October 22nd. Analysts expect Sartorius to post earnings of $1.42 per share and revenue of $1.01 billion for the quarter.
Sartorius Stock Performance
Shares of Sartorius stock opened at $243.86 on Wednesday. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. Sartorius has a twelve month low of $181.58 and a twelve month high of $243.86. The stock has a market cap of $8.35 billion, a price-to-earnings ratio of 113.42 and a beta of 0.98. The company’s fifty day moving average is $226.44 and its 200 day moving average is $218.94.
About Sartorius
Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.
The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.
Featured Stories
- Five stocks we like better than Sartorius
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
